Increased expression of TLR9 associated with pro-inflammatory S100A8 and IL-8 in diabetic wounds could lead to unresolved inflammation in type 2 diabetes mellitus (T2DM) cases with impaired wound healing

详细信息    查看全文

• 作者：Kanhaiya Singh^a ; Neeraj K. Agrawal^b ; Sanjeev K. Gupta^c ; Pratima Sinha^d ; ^{sinhapratima2008@gmail.com" class="auth_mail" title="E-mail the corresponding author} ; Kiran Singh^a ; ^{singhk4@rediffmail.com" class="auth_mail" title="E-mail the corresponding author} ; ^{skiran@bhu.ac.in" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Type 2 diabetes mellitus ; Wound healing impairment ; CD11b+ CD33+ myeloid cells ; TLR9 ; S100A8 ; IL-8
• 刊名：Journal of Diabetes and its Complications
• 出版年：2016
• 出版时间：January-February 2016
• 年：2016
• 卷：30
• 期：1
• 页码：99-108
• 全文大小：1160 K

文摘

Type 2 diabetes mellitus (T2DM) is characterized by persistent hyperglycemia which causes a chain of abrupt biochemical and physiological changes. Immune dys-regulation is the hallmark of T2DM that could contribute to prolonged inflammation causing transformation of wounds into non-healing chronic ulcers. Toll like receptor − 9 (TLR9) is a major receptor involved in innate immune regulation. TLR9 activation induces release of pro-inflammatory molecules like S100A8 and interleukin-8 (IL-8) by myeloid cells causing migration of myeloid cells to the site of inflammation. We hypothesized that pro-inflammatory S100A8 and IL-8 proteins could cause persistent inflammation in chronic wounds like diabetic foot ulcer (DFU) and may contribute to impaired wound healing in T2DM patients.

Materials and Methods

Expression of TLR9 and its downstream effector molecules S100A8, and IL-8 were analyzed in chronic diabetic wound and non-diabetic control wound tissue samples by semiquantitative reverse transcriptase - polymerase chain reaction (RT-PCR), quantitative RT-PCR, western blot and immunofluorescence. CD11b⁺CD33⁺ myeloid cells were analyzed by flow cytometry.

Results

TLR9 message and protein were higher in diabetic wounds compared to control wounds (p = 0.03, t = 2.21 for TLR9 mRNA; p = < 0.001, t = 4.21 for TLR9 protein). TLR9 down-stream effector molecules S100A8 and IL-8 were also increased in diabetic wounds (p = 0.003, t = 3.1 for S100A8 mRNA; p = 0.04, t = 2.04 for IL-8). CD11b⁺ CD33⁺ myeloid cells were decreased in T2DM as compared to non-diabetic controls (p = 0.001, t = 3.6). DFU subjects had higher levels of CD11b⁺ CD33⁺ myeloid cells as compared to non-DFU T2DM control (p = 0.003, t = 2.8). Infection in the wound microenvironment could be the cause of increase in CD11b⁺CD33⁺ myeloid cells in DFU (p = 0.03, t = 2.5).

Conclusion

The up-regulation of myeloid cell-derived pro-inflammatory molecules S100A8 and IL-8 in combination with lower levels of CD11b⁺ CD33⁺ myeloid cells may cause the impairment of wound healing in T2DM subjects leading to chronic ulcers.